A Community Pharmacist-led Intervention to Improve Screening of Sleep Apnea in Primary Care
1 other identifier
interventional
400
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility and the effectiveness of sleep apnea screening program for patients at risk in community pharmacies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 27, 2012
CompletedFirst Posted
Study publicly available on registry
March 13, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMarch 13, 2012
March 1, 2012
5 months
January 27, 2012
March 12, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients referred by the general practitioner to sleep specialist for SAS diagnosis test
6 months after the intervention of pharmacists.
Secondary Outcomes (2)
Satisfaction of patients and pharmacists
6 months after the intervention of pharmacist
Proportion of patients with sleep apnea
6 months after the intervention of pharmacists
Interventions
2 validated screening questionnaires (Berlin questionnaire, Epworth scale)
Eligibility Criteria
You may qualify if:
- Taking 1 or more anti-hypertension drugs
- Overweight (BMI \> 25)
- Snoring
- Signed informed consent
You may not qualify if:
- To have a sleep apnea treatment
- Not to have a referent doctor
- To have a long-term illness
- Did not sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cermes3, CNRS UMR8211 - Inserm U988
Villejuif, 94800, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalise Pelletier-Fleury
Institut National de la Santé Et de la Recherche Médicale, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 27, 2012
First Posted
March 13, 2012
Study Start
January 1, 2012
Primary Completion
June 1, 2012
Study Completion
December 1, 2012
Last Updated
March 13, 2012
Record last verified: 2012-03